Advertisement

Bullfrog AI Holdings, Inc. BFRG

Set alert

Price alert · BFRG

All alert types
0.49 USD -0.02 -3.62%

At close · Oct 30

0.48 -0.01 -1.21%

After hours · Oct 30, 4:43 PM ET

Bid
0.48 × 2
Ask
0.50 × 2
0.4756 Day range 0.4994
0.429 52-week range 1.68
YTD
-44.77%
1 year
-61.90%
Open
0.4908
Prev close
0.506
Mkt cap
9.04M
Vol
125.19K
Avg vol
5.37M
EPS
-0.46
P/E
0.00
Div yield
0.00%
More statistics
Low
0.4756
High
0.4994
Forward P/E
0.00
Beta
0.00
Short ratio
2.30
Inst. own
3.48%
Dividend
0.00
Ex-div date
50-d avg
2.33
200-d avg
2.64
1y target
0.00

2Y chart

Chart tools
Interval

Signals (93)
NameDateAgo
SMA: BearishOct 13, 20262 weeks ago
MACD: Sell SignalOct 12, 20262 weeks ago
SMA: BearishOct 9, 20263 weeks ago
SMA: BullishOct 6, 20263 weeks ago
SMA: BearishSep 25, 20261 month ago
SMA: BullishSep 23, 20261 month ago
RSI: OverboughtSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
MACD: Buy SignalSep 21, 20261 month ago
RSI: OversoldSep 16, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
MACD: Buy SignalAug 21, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
SMA: BearishJul 16, 20263 months ago
MACD: Sell SignalJul 16, 20263 months ago
SMA: BullishJun 30, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago
MACD: Sell SignalJun 25, 20264 months ago
MACD: Buy SignalJun 17, 20264 months ago
MACD: Sell SignalJun 11, 20264 months ago
MACD: Buy SignalMay 21, 20265 months ago
SMA: BearishApr 28, 20266 months ago
SMA: BearishApr 17, 20266 months ago
SMA: BullishApr 16, 20266 months ago
MACD: Sell SignalApr 13, 20266 months ago
SMA: BearishApr 8, 20266 months ago
SMA: BullishApr 7, 20266 months ago
SMA: BearishApr 6, 20266 months ago
SMA: BullishMar 31, 20267 months ago
SMA: BullishMar 30, 20267 months ago
MACD: Buy SignalMar 30, 20267 months ago
RSI: OverboughtMar 30, 20267 months ago
MACD: Sell SignalMar 24, 20267 months ago
MACD: Buy SignalFeb 18, 20268 months ago
RSI: OversoldFeb 12, 20268 months ago
RSI: OversoldFeb 5, 20268 months ago
MACD: Sell SignalJan 30, 20269 months ago
MACD: Buy SignalJan 22, 20269 months ago
RSI: OversoldJan 12, 20269 months ago
MACD: Sell SignalDec 26, 202510 months ago
MACD: Buy SignalNov 26, 202511 months ago
RSI: OversoldNov 19, 202511 months ago
RSI: OversoldNov 17, 202511 months ago
RSI: OversoldNov 6, 202512 months ago
SMA: BearishOct 29, 20251 year ago
SMA: BullishOct 23, 20251 year ago
SMA: BearishOct 22, 20251 year ago
MACD: Sell SignalOct 17, 20251 year ago
MACD: Buy SignalOct 15, 20251 year ago
SMA: BullishOct 13, 20251 year ago
SMA: BearishOct 10, 20251 year ago
MACD: Sell SignalOct 10, 20251 year ago
SMA: BullishSep 22, 20251 year ago
SMA: BearishSep 19, 20251 year ago
SMA: BullishSep 18, 20251 year ago
SMA: BearishSep 16, 20251 year ago
SMA: BullishSep 15, 20251 year ago
MACD: Buy SignalSep 8, 20251 year ago
MACD: Sell SignalSep 5, 20251 year ago
MACD: Buy SignalAug 22, 20251 year ago
MACD: Sell SignalAug 20, 20251 year ago
MACD: Buy SignalAug 18, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
MACD: Buy SignalJul 17, 20251 year ago
SMA: BearishJun 17, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
SMA: BullishJun 16, 20251 year ago
SMA: BearishJun 13, 20251 year ago
MACD: Buy SignalJun 10, 20251 year ago
SMA: BearishMay 29, 20251 year ago
MACD: Sell SignalMay 29, 20251 year ago
SMA: BullishMay 16, 20251 year ago
SMA: BearishMay 15, 20251 year ago
SMA: BullishMay 8, 20251 year ago
MACD: Buy SignalApr 11, 20251 year ago
MACD: Sell SignalApr 3, 20251 year ago
MACD: Buy SignalMar 21, 20251 year ago
SMA: BearishFeb 27, 20251 year ago
SMA: BullishFeb 26, 20251 year ago
SMA: BearishFeb 25, 20251 year ago
MACD: Sell SignalFeb 24, 20251 year ago
RSI: OverboughtFeb 13, 20251 year ago
RSI: OverboughtFeb 10, 20251 year ago
SMA: BullishJan 28, 20251 year ago
SMA: BearishJan 27, 20251 year ago
SMA: BullishJan 21, 20251 year ago
MACD: Buy SignalJan 21, 20251 year ago
MACD: Sell SignalJan 14, 20251 year ago
MACD: Buy SignalJan 6, 20251 year ago
MACD: Sell SignalDec 31, 20241 year ago
MACD: Buy SignalDec 26, 20241 year ago
MACD: Sell SignalDec 23, 20241 year ago

Key statistics

Market cap
18.65M
Enterprise value
15.37M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
286.86
Price / book
5.04
EPS (TTM)
-0.84
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
65.00K
Revenue growth
0.00%
Free cash flow
-3.42M
Total cash
5.61M
Total debt
341.04K
Return on equity
-117.94%
Shares outstanding
8.71M
Short % of float
5.69%
50-day average
2.33
200-day average
2.64

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
BFRG Revenue — quarterly 215.38K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BFRG Net income — quarterly -1.37M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BFRG EPS — quarterly -0.07
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

About Bullfrog AI Holdings, Inc.

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on BFRG — it syncs with the Stock Master app.

Insider holders

BFRG insider holders
InsiderRelationLatest transactionDateShares held
ENRIGHT WILLIAMDirectorPurchaseJun 13, 20235,000
SINGH VININDERChief Executive OfficerSaleOct 8, 20242,442,450

Institution ownership

BFRG institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc1.42%124,147265.67KSep 29, 2024
Fortem Financial Group, LLC0.59%51,400110.00KSep 29, 2024
Geode Capital Management, LLC0.41%35,95376.94KSep 29, 2024
Raymond James & Associates, Inc.0.17%15,00032.10KSep 29, 2024
Xtx Topco Ltd0.12%10,31722.08KSep 29, 2024
Morgan Stanley0.07%6,47613.86KSep 29, 2024

Fund ownership

BFRG fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.09%95,347204.04KSep 29, 2024
Vanguard Extended Market Index Fund0.33%28,80061.63KSep 29, 2024
Fidelity Extended Market Index Fund0.29%25,38154.31KOct 30, 2024
Fidelity Total Market Index Fund0.08%6,91014.79KOct 30, 2024
Fidelity Series Total Market Index Fund0.08%6,58414.09KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.04%3,4077.29KOct 30, 2024
Advertisement